• LY-411575: Gamma-Secretase Inhibitor for Advanced Research

  2026-07-07

  LY-411575 stands out as a benchmark gamma-secretase inhibitor, enabling precise modulation of amyloid beta and Notch signaling in Alzheimer’s and cancer research. This article breaks down its applied workflows, protocol parameters, and troubleshooting strategies for high-impact translational studies.

• Rucaparib (AG-014699): Precision Tools for DNA Repair Pathwa

  2026-07-06

  Explore how Rucaparib (AG-014699) enables unparalleled precision in dissecting DNA repair pathways and radiosensitization mechanisms in cancer biology research. This article delivers unique insight into assay design, transporter effects, and protocol optimization for advanced DNA damage response studies.

• CRISPR-Cas9 Editing of LGMN Suppresses Breast Cancer Metasta

  2026-07-06

  This study demonstrates that co-delivery of Cas9 mRNA and guide RNAs via lipid nanoparticles efficiently edits the LGMN gene and reduces metastatic potential in breast cancer models. The research clarifies optimized in vitro transcription protocols for gRNA and Cas9 mRNA, offering insights for gene-editing approaches targeting tumor metastasis.

• Placental miR-519d-3p Exosomes Disrupt Immune Tolerance in P

  2026-07-05

  This study uncovers how placenta-derived exosomes enriched in miR-519d-3p promote immune cell dysregulation at the maternal-fetal interface, contributing to preeclampsia pathogenesis. It demonstrates mechanistic links between exosomal miRNA signaling, T cell fate, and immune tolerance failure.

• Tyrothricin: Advanced Mechanisms and Emerging Research Horiz

  2026-07-04

  Explore Tyrothricin as a peptide antibiotic mixture with unique membrane-disrupting mechanisms. This in-depth article unveils advanced insights for antimicrobial research, integrating new perspectives on cellular iron homeostasis and practical assay design.

• Nanozyme-Functionalized Hydrogels Disrupt IDD’s ROS-Ferropto

  2026-07-03

  This study introduces a nanozyme-functionalized hydrogel capable of breaking the self-propagating cycle of ROS, ferroptosis, and inflammation in intervertebral disc degeneration (IDD). By leveraging a nucleus pulposus cell membrane-coated black phosphorus–cerium oxide nanozyme, the approach achieves durable antioxidant effects and suppression of pro-inflammatory signaling, offering a new paradigm for structural and functional disc repair.

• Rapid In Vivo and Cell-Based Screening in Pancreatic Cancer

  2026-07-03

  This study introduces a rapid, dual in vitro and in vivo screening platform leveraging Rgs16::GFP expression to evaluate chemotherapeutic combinations in pancreatic ductal adenocarcinoma (PDA). The approach enables efficient identification of drug synergies targeting early-stage lesions, with implications for accelerating preclinical development in cancer biology research.

• EZ Cap™ Cas9 mRNA (m1Ψ): Enhancing Genome Editing Precision

  2026-07-02

  EZ Cap™ Cas9 mRNA (m1Ψ) from APExBIO stands apart for its Cap1 structure and m1Ψ modification, enabling highly efficient, immune-evasive genome editing in mammalian cells. This guide details optimized workflows, troubleshooting insights, and the latest evidence on mRNA nuclear export control for superior CRISPR-Cas9 specificity.

• Translating Norepinephrine Bitartrate: From Mechanism to Mod

  2026-07-02

  This thought-leadership article provides translational researchers with a mechanistic, evidence-based, and strategically actionable framework for leveraging (-)-Norepinephrine (+)-bitartrate in cardiovascular and cardiomyopathy studies. It contextualizes recent clinical dosing insights, benchmarks competitive products, and delivers practical protocol guidance that bridges in vitro research with clinical realities.

• Optimizing Precision: m1Ψ-Capped Cas9 mRNA Strategies in CRI

  2026-07-01

  Translational researchers face persistent challenges in genome editing: balancing efficiency, specificity, and cellular compatibility, especially in mammalian systems. This article provides a mechanistic deep dive into how advanced mRNA design—specifically the integration of Cap1 structures and N1-Methylpseudo-UTP (m1Ψ) modifications—redefines the landscape of CRISPR-Cas9 genome editing. Building on recent insights into mRNA nuclear export and specificity modulation, we outline practical strategies for deploying EZ Cap™ Cas9 mRNA (m1Ψ) to maximize translational success while minimizing off-target effects and innate immune activation. The discussion goes beyond standard product pages, contextualizing new research and offering actionable guidance for experimental design.

• Cy7 NHS Ester: Practical Guide for Near-Infrared Protein Lab

  2026-07-01

  Cy7 NHS ester is a sulfonated, hydrophilic near-infrared protein labeling dye that addresses the challenge of sensitively tagging proteins and peptides in aqueous systems without using organic co-solvents. It is optimal for in vitro and in vivo fluorescent imaging but is not suitable for targets lacking accessible amino groups or for workflows requiring dye solution storage.

• GANT61 Induces Apoptosis in ALK+ ALCL via Hh-PIK3IP1-Akt Axi

  2026-06-30

  This study identifies GANT61 as an effective suppressor of proliferation and inducer of apoptosis in ALK-positive anaplastic large cell lymphoma (ALK+ ALCL) by targeting the Hedgehog-PIK3IP1-Akt signaling axis. The findings provide mechanistic insights for therapeutic intervention and establish foundations for advanced apoptosis detection strategies in hematologic malignancies.

• Plasmid-Mediated Carbapenemase Gene Spread in CREC: New Insi

  2026-06-30

  This study provides a detailed molecular characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from Guangdong, China, highlighting the predominance of plasmid-mediated blaNDM-1 and extensive multidrug resistance. The research informs on the dynamics of gene transfer and epidemiology during the COVID-19 era, with critical implications for resistance surveillance and laboratory modeling.

• Reactive Oxygen Species Assay Kit: Precision in Cancer Resea

  2026-06-29

  Unlock advanced insights into oxidative stress with the Reactive Oxygen Species Assay Kit. This article explores the science behind DCFH-DA fluorescent probes and uniquely connects ROS quantification to cutting-edge cancer therapy innovation.

• HNF4A-AS1 Downregulation Drives Sorafenib Resistance via Lip

  2026-06-29

  This study identifies the liver-specific lncRNA HNF4A-AS1 as a critical regulator of sorafenib resistance in hepatocellular carcinoma (HCC). Through multi-modal analyses, the authors show that reduced HNF4A-AS1 disrupts polyunsaturated fatty acid metabolism, suppressing ferroptosis and promoting drug resistance, highlighting a novel lipid metabolism-mediated mechanism and potential therapeutic targets.

546 records 12/37 page Previous Next First page 上5页 1112131415 下5页 Last page